(CIDRAP News) – Researchers in other countries have found evidence that circulating strains of Bordetella pertussis have adapted to the acellular vaccine, and researchers today reported similar findings for the first time in US kids, based on genetic analysis of isolates from hospitalized children.
(CIDRAP News) As of mid February, about 86 million Americans had received the pandemic H1N1 vaccine, and so far no worrisome signals have emerged from extensive safety monitoring, officials from the US Centers for Disease Control and Prevention (CDC) said today at a conference call with heathcare practitioners.
(CIDRAP News) Nearly 5 months after its launch, the pandemic H1N1 vaccine still appears to have a safety profile similar to that of seasonal flu vaccines, the US Centers for Disease Control and Prevention (CDC) said in an update yesterday.
(CIDRAP News) A Centers for Disease Control and Prevention (CDC) official estimated today that more than 75 million Americans, or close to 25% of the population, have been vaccinated against the pandemic H1N1 virus.
(CIDRAP News) Federal health officials today hosted a Web telecast to help pregnant women and new mothers prepare for an uptick in novel H1N1 flu infections, a day after a federal judge rejected an advocacy group's request to limit use of the H1N1 vaccine in pregnant women.
(CIDRAP News) – A flu vaccine manufacturer's decision not to build a US facility has highlighted the perpetual mismatch between flu-shot supply and demand—and the reality that the mismatch may undermine plans for pandemic flu vaccines.
(CIDRAP News) This in-depth article investigates the prospects for development of vaccines to head off the threat of an influenza pandemic posed by the H5N1 avian influenza virus. Its seven parts put advances in vaccine technology in perspective by illuminating the formidable barriers to producing an effective and widely usable vaccine in a short time frame.
Editor's note: This is the bibliography to a seven-part series launched October 25, 2007, investigating the prospects for development of vaccines to head off the threat of an influenza pandemic posed by the H5N1 avian influenza virus. The series puts advances in vaccine technology in perspective by illuminating the formidable barriers to producing an effective and widely usable vaccine in a short time frame.
(CIDRAP News) A federal interagency working group yesterday released a draft report detailing how the government would allocate limited vaccine supplies if a severe influenza pandemic grips the United States, offering a tiered approach that flags key health and public safety personnel and children as top priorities.